Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University Global Surgery Group has launched a new project on reducing childhood mortality and morbidity from injuries in Tanzania and Zimbabwe, funded by the National Institute for Health and Care Research (NIHR).

Medical practitioner holding a cute stethoscope

The launch took place on Sunday 1 December 2024 at the Rainbow Towers Hotel & Conference Centre in Harare, Zimbabwe. Around 15 participants attended, both in person and virtually, to discuss the project's four interlinked work packages; epidemiology, implementation of strategies to reduce childhood injuries, economic analyses, and a paediatric trauma Echo programme.

The project team, led by Professor Kokila Lakhoo from the Nuffield Department of Surgical Sciences, were introduced to the four doctoral candidates who have been successfully and competitively selected. From Zimbabwe, Dr Wilfred Muteweye will be undertaking a PhD in Work Package 2 (strategies to reduce childhood injuries) and Dr Naboth Matinhira in Work Package 3 (economic analyses), while from Tanzania, Dr Alphonce Simbila will be undertaking a PhD in Work Package 1 (epidemiology) and Dr Mohamed Salim in Work Package 4 (paediatric trauma programme).

The session concluded with networking opportunities and a steering committee meeting that clarified supervision frameworks for doctoral candidates and data collectors, and underscored the importance of embedding research directly into clinical services.

Read more about the project, 'Reducing childhood mortality and morbidity from injuries in Tanzania and Zimbabwe', on the NIHR website. 

 

Read the story on the Nuffield Department of Surgical Sciences website.

 

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.